Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) Director Daniel N. Swisher, Jr. so...
Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) insider William Guyer sold 35,007 ...
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider William Guyer sold 35,007 ...
Corcept Therapeutics’ second quarter was marked by continued sales growth in its core endocrinology ...
Biopharma company Corcept Therapeutics (NASDAQ:CORT) missed Wall Street’s revenue expectations in Q2...